Resource Center: Managing challenging patients
Results 1 - 10 of 17
Search Results
Description:
Developed by a consensus panel, these guidelines provide treatment recommendations for patients with dual disorders.
Source:
U.S. Department of Health and Human Services, SAMHSA
Tags:
- Screening and diagnosis
- Special populations
- Managing challenging patients
- Addiction
- Assessment
- Behavioral therapy
- Comorbidities
- Complicated patients
- Dependence
- Drug interactions
- Expert panel
- Pharmacology
- Pharmacotherapy
- Pharmacy
- Polysubstance use
- Psychiatric
- Psychosocial
- Referral
- Relapse
- Risk factors
- Screening
- Side effects
- Special populations
- Symptoms
- Tolerance
- Withdrawal
- Treatment Algorithm
- Experienced prescriber
- Just became waivered
- Need to refer
Description:
This chapter from TIP 43: Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs discusses the use of drug testing as a means of monitoring patient progress and treatment efficacy. This chapter details several methods for implementing drug testing, their effectiveness, and their pros and cons.
Source:
Center for Substance Abuse Treatment (CSAT)
Tags:
Description:
This study examined the efficacy of methadone in relieving cancer pain and also discusses side effects.
Source:
Cochrane Reviews (3 votes)
Tags:
Description:
This article describes how to identify drug-seeking patients, and explains risk management measures.
Source:
American Family Physician, 2000 (3 votes)
Tags:
Setting Rules and Expectations
Description:
Discusses the importance of setting guidelines for patients in an office-based buprenorphine program and gives examples of the types of procedures and protocol that should be set and agreed upon prior to beginning treatment. Perhaps the most obvious thing that the physician and patient need to address is the functioning of the office-based buprenorphine program.
Tags:
Urine Testing in Buprenorphine Treatment
Description:
Information on the logistics of urine testing, including the timing of testing, frequency, location, and test type. Being able to accurately gauge the current drug use by patients enrolled in a substance abuse program is essential; self-reports, family member reports, observation of attitude alteration, and behav
Tags:
Description:
This 2010 Physician Clinical Support System (PCSS) document written by Dr. Judith Martin discusses types of aberrant behavior associated with buprenorphine and steps that can be taken to reduce the risk of abuse and diversion.
Source:
Physician Clinical Support System (PCSS)
Tags:
Description:
RADARS®, the Researched Abuse, Diversion, and Addiction-Related Surveillance System, tracks prescription drug abuse, misuse and diversion throughout the United States. It is a nonprofit operation of the Rocky Mountain Poison and Drug Center, a division of Denver Health.
Source:
RADARS® (3 votes)
Tags:
Urine Testing
Description:
Basic information on urine testing in potential opioid-dependent patients. This table provides basic information on urine testing in potential opioid-dependent patients.
Tags:
Description:
Article describing eight different ways to identify and help drug-seeking patients in your practice.
Source:
Medical Economics (3 votes)
Tags:
